Same Data, Same Day, Different Decision: FDA, EMA On Roche's Protease Inhibitor Invirase
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA goes for a new warning and a MedGuide; EMA calls for a lower starting dose.